Marex Group plc
MRXQUIET ISSUERQUIETMarex Group plc reads as an Quiet Issuer (composite 32/100); Selective Buyer deploying $328M across 0 disclosed transactions, newly disclosed vs the prior cycle · primary market Financial Infrastructure.
Lens
Disclosed M&A capital (2023–2025)
$328M
vs N/A in 2020–2022
Disclosed transactions
N/A
2/3 active fiscal years in window
Buyer archetype
Selective Buyer
Acquisition use is visible but targeted.
Composite score
32
Quiet Issuer dominates · Quiet
Behavioral posture, nine reads.
Each index scores the issuer 0–100 against an EDGAR-anchored definition. Scores ≥ threshold elevate the issuer into the index's constituent set; the dominant index drives the masthead label.
Active Acquirer
Companies actively deploying disclosed capital into M&A
- $328M disclosed buyer spend
Buyer Cadence
Buyer-side companies with recent filing activity
Target Probability
Issuers showing target-side patterns from filings
Spin/Carve
Issuers showing spin-off, carve-out, or sum-of-parts posture
Pressure Watch
Issuers facing activism, governance, or control pressure
Distress Watch
Issuers showing financial-distress filing patterns
- Missing recent 10-Q
Restatement Risk
Issuers with accounting-integrity flags from filings
Capital Velocity
Issuers with the highest filing-activity intensity
Quiet Power
Large issuers with low signal volume and clean disclosure cadence
- Enterprise value $7.9B
- Quiet signals
Capital cadence.
Ten-year disclosed M&A activity. Bars show spend ($MM); ticks show recorded transaction count. Disclosure tier annotated where v6 audited corpus carries an entry.
Disclosed spend $MM Disclosed transactions (right axis)Peak spend year: $314M · Peak count: 1
| FY | Disclosed buys | Disclosed spend | Avg ticket | Audited tier |
|---|---|---|---|---|
| 2025 | N/A | $314M | N/A | N/A |
| 2024 | N/A | $14M | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
Strategy posture.
The buyer's playbook in terms of strategic archetype: what each disclosed move says about how they're deploying capital.
Strategy keywords
Terms recurring across recent 10-K acquisition disclosures.
- geographic_expansion
- platform
- horizontal_consolidation
- technology_acquisition
- bolt_on
Filing language.
Direct excerpts from acquisition disclosures and strategy sections: the verbs the buyer chose, in the filings they signed.
“We also market products in Canada for the treatment of dermatological and aesthetic conditions and began commercial efforts in Europe with our acquisition of LipoSonix, Inc. in July 2008.”
“Graceway’s commercial pharmaceutical product portfolio includes on-market prescription products and important development projects primarily in dermatology and women’s health specialties”
“business acquisitions of Winterflood in 2025 and in prior years: ED&F Man Capital Markets business, the OTCex group and Cowen's Prime Services and Outsourced Trading business.”
“LipoSonix is a medical device company developing non-invasive body sculpting technology.”
“acquired substantially all of the assets of Graceway Pharmaceuticals, LLC”
Market context.
Where this issuer sits inside its SE-Cluster rollup wedge, with disclosed-spend rank plus trading comparables against the public peer set.
Primary market
Financial Infrastructure
- Market spend (2023–2025)
- $186.1B
- Market spend (2020–2022)
- $98.1B
- Recent vs prior
- +90%
- Issuer rank in market
- N/A
- Share of market capital
- 0.0%
Valuation positioning
MRX trades at a -9.7-turn discount to the Financial Infrastructure peer median of 16.2×.
- EV / Revenue
- 2.2×
- Net debt / EBITDA
- -1.3×
- Peer median EV / EBITDA
- 16.2×
Trading comparables
FMP market data · 2026-05-10
| Company | EV / EBITDA | EV / Rev | Net debt / EBITDA | Revenue | M&A 2023–2025 |
|---|---|---|---|---|---|
| 22.0× | 14.5× | -0.4× | $43B | $1.8B | |
| 21.4× | 10.8× | 1.4× | $7.9B | $451M | |
| 16.2× | 8.2× | 3.2× | $13.1B | $10.3B | |
| 10.9× | 3.9× | 5.4× | $8.8B | $5.1B | |
Marex Group plcMRX | 6.5× | 2.2× | -1.3× | $6.5B | $328M |
| 2.3× | 2.7× | -1.1× | $187B | $81.8B |
Trading multiples from FMP market data; disclosed M&A spend from the SE-Cluster EDGAR 10-K corpus. Peer set = top disclosed buyers in Financial Infrastructure. Bars scaled to the highest EV/EBITDA in the set.
Target landscape.
Public-issuer targets that fit this buyer's archetype and target categories from filing-derived signal. Scores reflect cross-signal fit; reasons cite the EDGAR-anchored facts that drove the match.
No qualifying public-issuer targets surfaced from the current signal mix.
Stated target categories
No target categories enumerated in the audited corpus for this issuer.
Filing activity & signal stream.
Filing cadence and event-driven signals visible on EDGAR. The signal stream below is curated from restatement / spin-carve / activism categories, providing context for any near-term call.
Filing cadence
- 10-K (annual)22026-03-25
- 10-Q (quarterly)0N/A
- 8-K (event)0N/A
- Proxy / DEF 14A0N/A
- Activism (13D / DFAN / PREC)0N/A
Signals on file
Clean signal stream: no restatement, NT, spin / carve, or activism filings on file.
Audited corpus.
No audited record on file for this CIK in the current v6 corpus.
This issuer has not been extracted into the v6 audited acquirer corpus yet. The brief above pulls from ranking-level aggregates and issuer-index signal only.